Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis

NCT00537550 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT00537550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00537550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GIMEMA Guidelines for the Treatment of Adult ALL Affected Patients at Diagnosis
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2000
Completion date
June 30, 2006
Enrollment
Not reported
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphocytic, acute